Physician profile
Mary E Benton
NPI 1669465688
$865.72
in general payments reported to CMS, 2019-2025
15 companies · $111 in 2025
The $111 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184 · 2020: $98.03 · 2021: $109 · 2022: $103 · 2023: $124 · 2024: $138 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $372.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $372.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $237.93 | 2019-2025 | Bexsero, Penmenvy |
| Ironshore Pharmaceuticals INC. | $115.53 | 2019-2024 | Jornay Pm |
| Pfizer INC. | $104.19 | 2019-2024 | |
| Tris Pharma INC | $87.41 | 2020-2022 | |
| Corium, LLC | $85.96 | 2022-2025 | Azstarys |
| Supernus Pharmaceuticals, INC. | $54.61 | 2021-2022 | |
| Novo Nordisk INC | $41.37 | 2023-2024 | Wegovy |
| Merck Sharp & Dohme LLC | $28.51 | 2021-2024 | Proquad, Gardasil, Rotateq |
| Adlon Therapeutics L.P. | $17.97 | 2019 | |
| Boston Scientific Corporation | $16.88 | 2025 | General - Pain Management |
| Takeda Pharmaceuticals U.S.A., INC. | $16.48 | 2021 | |
| Alexion Pharmaceuticals, INC. | $16.00 | 2019 | |
| Cranial Technologies, INC | $15.79 | 2025 | Doc Band |
| Sanofi Pasteur INC. | $14.67 | 2023 | |
| Sobi, INC | $12.42 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Benton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.